» Articles » PMID: 8186998

Corticotropin Releasing Factor Neurons Are Innervated by Calcitonin Gene-related Peptide Terminals in the Rat Central Amygdaloid Nucleus

Overview
Journal Brain Res Bull
Specialty Neurology
Date 1994 Jan 1
PMID 8186998
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The central nucleus of the rat amygdala (CeA) contains many corticotropin releasing factor (CRF) immunoreactive neurons. Previous studies have demonstrated that these CRF neurons project to brain stem regions responsible for modulation of autonomic outflow. Calcitonin gene-related peptide (CGRP) terminals overlap the distribution of CRF cell bodies in the CeA. These CGRP terminals mainly originate from cell bodies that are located in the pontine parabrachial nucleus. The present study examined the possibility that CRF cell bodies are innervated by CGRP terminals. The results suggest that over 35% of the CRF neurons in the CeA are contacted by CGRP terminals as judged by the indiscernible distances between the terminals and cell bodies and or dendrites. In addition, a dual-labeled electron microscopic technique demonstrates that CGRP terminals form synaptic contacts with CRF cell bodies and dendrites. This suggests that CGRP neurons in the parabrachial nucleus can modulate the activity of CRF amygdaloid brain stem efferents. Previous studies have shown that CRF, when administered into the central nervous system, produces increases in heart rate, blood pressure, and plasma catecholamines. CGRP administration into the amygdala has been shown to have a similar effect on the autonomic nervous system. It is, therefore, possible that CGRP could exert these effects via an amygdaloid CRF pathway.

Citing Articles

Altered volume of the amygdala subregions in patients with chronic low back pain.

Gu S, Shi F, Wang S, Wang C, Yao X, Sun Y Front Neurol. 2024; 15:1351335.

PMID: 38606278 PMC: 11007205. DOI: 10.3389/fneur.2024.1351335.


From aversive associations to defensive programs: experience-dependent synaptic modifications in the central amygdala.

Penzo M, Moscarello J Trends Neurosci. 2023; 46(9):701-711.

PMID: 37495461 PMC: 10529247. DOI: 10.1016/j.tins.2023.06.006.


Pain-related cortico-limbic plasticity and opioid signaling.

Neugebauer V, Presto P, Yakhnitsa V, Antenucci N, Mendoza B, Ji G Neuropharmacology. 2023; 231:109510.

PMID: 36944393 PMC: 10585936. DOI: 10.1016/j.neuropharm.2023.109510.


Sex Differences in CGRP Regulation and Function in the Amygdala in a Rat Model of Neuropathic Pain.

Presto P, Neugebauer V Front Mol Neurosci. 2022; 15:928587.

PMID: 35726298 PMC: 9206543. DOI: 10.3389/fnmol.2022.928587.


Kappa Opioid Receptor Blockade in the Amygdala Mitigates Pain Like-Behaviors by Inhibiting Corticotropin Releasing Factor Neurons in a Rat Model of Functional Pain.

Yakhnitsa V, Ji G, Hein M, Presto P, Griffin Z, Ponomareva O Front Pharmacol. 2022; 13:903978.

PMID: 35694266 PMC: 9177060. DOI: 10.3389/fphar.2022.903978.